Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • MultiCell Technologies News

    -   $ -99,00% -0,0001 $
    In : -    € | 11.04.24 17:18:44 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A0ET6A
    ISIN: US62544S2005
    US-Symbol: MCET
    Typ: Aktie

    MultiCell Technologies News

    25.08.14 - PR Newswire
    MultiCell Technologies Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer
    MultiCell Technologies Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer PR Newswire
    20.03.14 - PR Newswire
    MultiCell Technologies Files U.S. and International Patent Applications for the Treatment of Liver Cancer
    MultiCell Technologies Files U.S. and International Patent Applications for the Treatment of Liver Cancer PR Newswire
    15.01.14 - PR Newswire
    MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics
    MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics PR Newswire
    13.11.13 - PR Newswire
    MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of MCT-485, a Noncoding miRNA for Cancer Treatment
    MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of MCT-485, a Noncoding miRNA for Cancer Treatment PR Newswire
    02.10.13 - PR Newswire
    MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer
    MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer PR Newswire
    06.08.13 - PR Newswire
    MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer
    MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer PR Newswire
    16.05.13 - PR Newswire
    MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer
    MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer PR Newswire
    26.12.12 - PR Newswire
    MultiCell Technologies Delivered Presentation at 2012 ASCB Meeting
    MultiCell Technologies Delivered Presentation at 2012 ASCB Meeting PR Newswire
    22.10.12 - PR Newswire
    Grant G. Miller Joins Board of MultiCell Technologies
    Grant G. Miller Joins Board of MultiCell Technologies PR Newswire
    27.09.12 - PR Newswire
    MultiCell Technologies To Announce Positive Preclinical Results at 2012 ASCB Meeting
    MultiCell Technologies To Announce Positive Preclinical Results at 2012 ASCB Meeting PR Newswire
    06.09.12 - PR Newswire
    Scott Lukeman, Ph.D., Joins Board of MultiCell Technologies
    Scott Lukeman, Ph.D., Joins Board of MultiCell Technologies PR Newswire
    14.08.12 - PR Newswire
    MultiCell Announces Results of Shareholders' Meeting
    MultiCell Announces Results of Shareholders' Meeting PR Newswire
    10.08.12 - PR Newswire
    MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models
    MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models PR Newswire

    Newssuche

    Videos

    newspaper
    16.04.24 +5,00%
    Technical Trading: Natural Gas Long Chance
    Erdgas Long Typ: Turbo Open End WKN: VM6KAH Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »